ResMed's Options Frenzy: What You Need to Know
Portfolio Pulse from Benzinga Insights
Financial giants have shown a bearish sentiment towards ResMed (NYSE:RMD) through unusual options trades. Analysis reveals a mix of bullish and bearish trades, with a significant focus on a price range of $170.0 to $230.0. ResMed's stock is currently trading at $208.09, with an upcoming earnings announcement in 2 days. RBC Capital maintains a Sector Perform rating with a target price of $204.0.
July 30, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ResMed (NYSE:RMD) has seen a mix of bullish and bearish options trades, with a significant focus on a price range of $170.0 to $230.0. The stock is currently trading at $208.09, down by -0.22%. RBC Capital maintains a Sector Perform rating with a target price of $204.0. An earnings announcement is expected in 2 days.
The bearish sentiment from financial giants and the current stock price being close to the target price of $204.0 suggest a potential short-term decline. The upcoming earnings announcement adds uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100